| Type | Public |
| HQ | Newark, US |
| Founded | 2008 |
| Size (employees) | 43 (est) |
| Website | ibioinc.com |
iBio was founded in 2008 and is headquartered in Newark, US
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataiBio Office Locations
iBio has an office in Newark
Newark, (HQ)
100 9 Innovation Way
Report incorrect company information
iBio Financials and Metrics
iBio Revenue
iBio's revenue was reported to be $444 k in FY, 2018
| USD | |
|---|---|
Revenue (FY, 2018) | 444.0k |
EBIT (FY, 2018) | (14.2m) |
Market capitalization (4-Dec-2018) | 14.2m |
Closing stock price (4-Dec-2018) | 0.8 |
Cash (30-Jun-2018) | 15.9m |
iBio's current market capitalization is $14.2 m.
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 819.0k | 349.0k | 160.0k | 134.0k | 379.0k | 135.0k | 75.0k | 37.0k | 122.0k | 153.0k | 353.0k | |||
General and administrative expense | 949.0k | 1.1m | 951.0k | 1.1m | 1.2m | 1.4m | 1.7m | 2.4m | 2.5m | 2.4m | 2.8m | 2.5m | 2.6m | 7.7m |
R&D expense | 552.0k | 585.0k | 343.0k | 1.2m | 815.0k | 551.0k | 704.0k | 1.0m | ||||||
Operating expense total | (240.0k) | 1.6m | 1.3m | 2.2m | 2.0m | 2.0m | 2.4m | 3.5m | 3.3m | 3.4m | 4.0m | 3.5m | 3.6m | 10.6m |
- Source: SEC Filings
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 3.4m | 5.7m | 4.3m | 3.5m | 8.1m | 8.4m | 6.7m | 21.9m | 20.1m | 16.3m | 12.4m | 5.9m | 7.3m | 3.4m |
Current Assets | 4.6m | 6.9m | 5.5m | 4.1m | 9.0m | 9.1m | 7.2m | 22.7m | 20.5m | 16.7m | 13.0m | 6.4m | 7.8m | 4.0m |
PP&E | 5.0k | 7.0k | 20.0k | 14.0k | 10.0k | 14.0k | 25.8m | 25.6m | 25.5m | 25.8m | 25.3m | 25.3m | 25.3m | |
Total Assets | 7.3m | 9.6m | 8.2m | 6.7m | 11.4m | 11.4m | 9.4m | 50.7m | 48.1m | 44.2m | 40.7m | 33.4m | 34.8m | 31.0m |
Annual
Quarterly
| USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 379.0k | (1.2m) | (1.3m) | (1.4m) | (1.7m) | (1.8m) | (4.1m) | (3.6m) | ||||||
Depreciation and Amortization | 88.0k | 176.0k | 89.0k | 92.0k | 184.0k | 537.0k | 412.0k | 826.0k | 1.3m | 423.0k | 848.0k | 1.3m | ||
Accounts Payable | 1.1m | 200.0k | 815.0k | 171.0k | 190.0k | 342.0k | 53.0k | (255.0k) | 7.0k | (78.0k) | (163.0k) | 102.0k | ||
Cash From Operating Activities | (911.0k) | (2.2m) | (570.0k) | (1.1m) | (2.8m) | (5.2m) | (2.3m) | (5.8m) | (9.4m) | (3.0m) | (6.6m) | (10.1m) |
| USD | Y, 2018 |
|---|---|
Revenue/Employee | 10.3k |
Financial Leverage | 2.7 x |
iBio Revenue Breakdown
iBio revenue breakdown by geographic segment: 100.0% from United States and 0.0% from Other
Report incorrect company information
iBio Blogs
December 03, 2018
iBio to Present at Brazilian Ministry of Health’s Plant-Made Pharmaceutical Meeting
NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a developer and manufacturer of biotherapeutics, today announced that it will present at the Plant-Based Technology Trends Meeting being held in Meireles, Fortaleza, Brazil from December 2-4, 2018. The meeting is sponsor…
October 02, 2018
iBio and CC-Pharming Hold First Design and Strategy Meeting
Texas Meeting Initiates Plan to Bring Economical, Plant-Derived Rituximab to China Market
NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) today announced the beginning of a four-day design and strategic planning meeting with executives and technical experts from CC-Ph…
August 22, 2018
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
NEW YORK, Aug. 22, 2018 (GLOBE NEWSWIRE) -- IBIO, INC. (NYSE AMERICAN: IBIO) (“IBIO” OR THE “COMPANY”), today announced that NYSE Regulation has accepted the Company’s plan to regain compliance with the Exchange’s continued listing standards set forth in Section 1003(a)(iii) of the NYSE American …
iBio Company Life and Culture
Report incorrect company information
iBio Frequently Asked Questions
When was iBio founded?
iBio was founded in 2008.
How many employees does iBio have?
iBio has 43 employees.
What is iBio revenue?
Latest iBio annual revenue is $444 k.
What is iBio revenue per employee?
Latest iBio revenue per employee is $10.3 k.
Who are iBio competitors?
Competitors of iBio include Lexicon Pharmaceuticals, Oxford Genetics and Spring Bank Pharmaceuticals.
Where is iBio headquarters?
iBio headquarters is located at 100 9 Innovation Way, Newark.
Where are iBio offices?
iBio has an office in Newark.
How many offices does iBio have?
iBio has 1 office.